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Abstract:  Sulfated polysaccharides and their lower molecular weight oligosaccharide 
derivatives from marine macroalgae have been shown to possess a variety of biological 
activities. The present paper will review the recent progress in research on the structural 
chemistry and the bioactivities of these marine algal biomaterials. In particular, it will 
provide an update on the structural chemistry of the major sulfated polysaccharides 
synthesized by seaweeds including the galactans (e.g., agarans and carrageenans), ulvans, 
and fucans. It will then review the recent findings on the anticoagulant/antithrombotic, 
antiviral, immuno-inflammatory, antilipidemic and antioxidant activities of sulfated 
polysaccharides and their potential for therapeutic application.  
Keywords:  sulfated polysaccharide; marine macroalgae; carbohydrate structure; 
bioactivity; oligosaccharides 
 
1. Introduction 
Many species of seaweed (marine macroalgae) are used as food and they have also found use in 
traditional medicine because of their perceived health benefits. Seaweeds are rich sources of sulfated 
polysaccharides, including some that have become valuable additives in the food industry because of 
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their rheological properties as gelling and thickening agents (e.g., carrageenan). In addition, sulfated 
polysaccharides are recognized to possess a number of biological activities including anticoagulant, 
antiviral, and immuno-inflammatory activities that might find relevance in nutraceutical/functional 
food, cosmetic/cosmeceutical and pharmaceutical applications.  
In this review, we will examine current progress in research on sulfated polysaccharides, relating to 
their structural diversity, bioactivities and mechanisms of action. The literature contains vast 
information on the structure and bioactivities of marine sulfated polysaccharides that cannot be 
completely considered in this short review. There are several excellent reviews where the reader may 
find additional information on various aspects of this subject [1–9].  
2. Structural Diversity of Algal Sulfated Polysaccharides 
2.1. Carrageenans and Agarans from Red Algae 
Red seaweed galactans are of great commercial importance as they are used widely in the food 
industry because of their rheological properties as gelling and thickening agents. These sulfated 
polysaccharides are primarily classified as agarans and carrageenans based on their stereochemistry, 
specifically galactans with 4-linked α-galactose residues of the L-series are termed agarans and those 
of the D-series are termed carrageneens [10]. Thus, carrageenans are high molecular weight sulfated  
D-galactans composed of repeating disaccharide units with alternating 3-linked -D-galactopyranose 
(G-units) and 4-linked -galactopyranose (D-units) or 3,6-anhydro--galactopyranose (AnGal-units).  
Carrageenans are normally classified according to their structural characteristics, including their 
sulfation patterns and the presence or absence of AnGal on D-units. There are at least 15 different 
carrageenan structures [2]. The most industrially relevant carrageenans are κ,  ι and λ forms, the 
structures of which are illustrated in Figure 1. The major source of -carrageenan is the red seaweed 
Kappaphycus alvarezii [11]. Its structure was reported as alternating 3-linked -D-galactose 4-sulfate 
and 4-linked AnGal units [12]. The -carrageenans have an additional sulfate group on C2(O) of the 
AnGal residue, resulting in two sulfates per disaccharide repeating unit. Funami et al. examined   
-carrageenan extracted from Eucheuma spinosum using atomic force microscopy and suggested that  
-carrageenans were more homogeneous and flexible than -carrageenans [13]. The -carrageenans 
have three sulfate groups per disaccharide unit with the third sulfate group of this form at the C6 
position of the 4-linked residue, but there is no 3,6-anhydride bridge on the 4-linked residues.   
Lambda-carrageenan is obtained from species of the Gigartina and Chondrus genera [14].  
Alternative forms of carrageenan can be obtained by chemical modification. For example, 
formation of an anhydride bridge in -carrageenan can be induced by alkali modification to produce  
-carrageenan (Figure 1). Extraction of -carrageenan from hand-sorted tetrasporophytes of Gigartina 
skottsbergii and subsequent treatment of the extract with alkaline borohydride resulted in conversion 
of the 4-linked residues to the 3,6-anhydride ring form, yielding -carrageenan with no detectable 
contamination of - or -carrageenans [15].  
Natural carrageenans typically occur as mixtures of different hybrid types, such as /-hybrids [16], 
/-hybrids [17–20], /-hybrids [21], or /-hybrids [22]. Additionally, methyl or pyruvic acid acetal 
constituents and the presence of small amount of other sugars can add to the structural complexity [23]. Mar. Drugs 2011, 9 
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Figure 1. Repeating disaccharide units of different types of carrageenan and their 
transformation by treatment with alkali. 
 
One of the best studied agarans is porphyran [24], obtained from Porphyra species of red algae 
including Porphyra capensis [25] and P. haitanensis [26,27]. Porphyran typical exhibits a linear 
backbone of alternating 3-linked β-D-galactose and 4-linked α-L-galactose-6-sulfate or   
3,6-anhydro-α-L-galactose units. Sulfated agarans of a similar linear form are synthesized by 
Polysiphonia species, such as P. strictissima, P. abscissoides [28], P. nigrescens [29], and P. atterima 
[30]. The regular agaran backbone may be interrupted by different O-linked substitutions in addition to 
sulfate including methyl and xylosyl groups adding to the structural diversity. For example, Prado et al. 
recently reported that the sulfated agaran from P. nigrescens is highly substituted on the C-6 of   
β-D-galactose with sulfate, but methyl ether and β-D-xylose residues were also present [29]. Agaran 
from Acanthophora spicifera, is highly sulfated at the C-2 position of β-D-galactose units, with some 
of the residues being 4,6-pyruvylated [31]. This agaran also contains small amounts of xylose and 
sulfated xylose residues [31,32].  
In addition to carrageenans and agarans, there are also red seaweed sulfated polysaccharides that 
have 4-linked D- and L-galactose sugars distributed within the same polysaccharide molecules,   
so-called  DL-hybrids, and others with various substitutions involving sulfate groups, pyruvic acid 
ketals, and methoxyl groups [33]. Indeed, native polysaccharides are rarely in their uniform or “ideal” 
form. For example, we recently reported on the existence of a carrageenan-like sulfated galactan from 
Furcellaria lumbricalis composed of κ/β-carrageenan units, non-sulfated galactan units, and also 
smaller units containing 3-O-methyl-galactose [16]. Another example of non-ideal sulfated galactans 
are xylogalactans, first described in the red seaweed Corallina officinalis and termed corallinan [34], 
which are agarans that have β-D-xylosyl groups attached at the O-6 position of D-galactose  
units [35–37]. 
It should be noted that red seaweeds also produce other types of sulfated polysaccharides including 
those with mannose in their backbones [38,39]. For example, Mandal et al. described xylomannnan Mar. Drugs 2011, 9 
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from  Scinaia hatei consisting primarily of a backbone of α-(1→3)-linked  D-mannose residues 
substituted at C-6, C-4, and C-2 with β-D-xylosyl residues [39]. 
2.2. Sulfated Polysaccharides from Green Algae 
Ulvan is the major water-soluble polysaccharide found in green seaweed of the order Ulvales (Ulva 
and  Enteromorpha sp.) that has sulfate, rhamnose, xylose, iduronic and glucuronic acids as main 
constituents [40,41]. As reviewed by Lahaye and Robic, ulvan structure shows great complexity and 
variability as evidenced by the numerous oligosaccharide repeating structural units identified in native 
and chemically modified ulvan preparations [3]. The main repeating disaccharide units reported are 
ulvanobiouronic acid 3-sulfate types containing either glucuronic or iduronic acid (Figure 2). 
Additionally, minor repeat units have been reported that contain sulfated xylose replacing the uronic 
acid or glucuronic acid as a branch on O-2 of the rhamnose-3-sulfate [40,42].  
Figure 2. The main repeating disaccharide units of ulvan. A. [→4)--D-Glcp-(1→4)--L-
Rhap3S-(1→]n; B. [→4)--L-Idop-(1→4)--L-Rhap3S-(1→]n. 
 
Although the most common source of sulfated galactans is red macroalgae, some green algae, 
particularly Codium species, are a significant source of sulfated galactans [43–45]. Sulfated galactans 
from green algae tend to be more complex and heterogeneous in structure than their counterparts from 
red algae. For example, C. fragile and C. cylindricum contain sulfated arabinogalactan and sulfated 
glucogalactan, respectively [43,46]. Bilan et al. reported a highly ramified sulfated galactan from 
C. yezoense that contained a linear backbone of 3-linked -D-galactopyranose residues containing 
short oligosaccharides branches through (1→6) linkages [47]. Sulfate groups were found mainly at C-4 
and in minor amounts at C-6. Polysaccharides containing sulfated galactans from other green seaweeds 
including Caulerpa and Ulva have been reported [48,49], but the galactans are minor components.  
A variety of other forms of sulfated polysaccharides are synthesized by green seaweeds [41,50–53]. 
This includes, for example, a water-soluble heteroglycuronan from Enteromorpha compressa, 
composed of (1→2,4)-linked rhamnose, (1→4)-linked xylose, and (1→4)-linked glucuronic acid 
units [52]. Sulfate groups, when present, were situated at the C-3 of rhamnose and the C-2 of xylose. 
Recently, a rhamnan sulfate from Monostroma nitidum was shown to consist primarily of α-1,3-linked 
and α-1,2-linked rhamnose residues [51].  
2.3. Fucose-containing Sulfated Polysaccharides from Brown Algae 
Fucans are sulfated polysaccharides that are composed of a fucose backbone. One of the best 
studied fucans from brown algae is fucoidan, which was first isolated by Kylin in 1913 [54]. The Mar. Drugs 2011, 9 
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fucoidan from Fucus vesiculosus has been available commercially for decades (Sigma-Aldrich 
Chemical Company, St. Louis, MO, U.S.). Early work on its structure showed that it contained 
primarily (1→2) linked 4-O-sulfated fucopyranose residues [55]. However, 3-linked fucose with   
4-sulfated groups were subsequently reported to be present on some of the fucose residues [56]. 
Additionally, it was determined to contain branches every 2–3 fucose residues. These early structures 
of fucoidan from F. vesiculosus are illustrated in Figure 3. Subsequently, Chevolot and colleagues 
reported that the fucoidan from F. vesiculosus and Ascophyllum nodosum contains a predominant 
disaccharide motif containing sulfate at the 2-position of the 3-linked fucose and sulfate groups on the 
2- and 3-positions of the 4-linked fucose [57]. 
Figure 3. Structure of fucoidan prepared from F. vesiculosus by Percival (A) [55] and 
Patankar (B) [56]. 
 
Fucans can differ in structure among algal species and can vary even within the same species. 
Because of the heterogeneity in structures within seaweed, differing extraction conditions used by 
researchers can give rise to the isolation of distinct fucan forms [4]. Fucans have been classified into 
two groups [58]. One group includes the fucans from Laminaria saccharina, L. digitata, Analipus 
japonicus, Cladosiphon okamuranus, and Chorda filum that have their central chains composed of 
(1→3)-linked -L-fucopyranose residues. A second group included fucans isolated from Ascophyllum 
nodosum  and  Fucus  species that have their central chains composed of repeating (1→3)- and   
(1→4)-linked -L-fucopyranose residues. However, many studies have revealed more complex fucans 
some with branching structures. A fucoidan isolated from Turbinaria conoides was shown to be highly 
complex, with 33–34% terminals, 27–28% linked and 21–22% branched in the (1→3)-linked main 
chain [59]. Representative fucan structures are illustrated in Table 1. Mar. Drugs 2011, 9 
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Table 1. Representative structures reported for fucans from brown algae. 
Species Fucoidan  structures  Reference 
Analipus japonicus  3 (4Fucp) and 1 (2Fucp) per ten (1→3)--L-Fucp(2/4SO3
-) residues  Bilan et al., 2007 [60] 
Ascophyllum 
nodosum 
→3)--L-Fucp(2SO3
-)-(1→4)--L-Fucp(2,3-diSO3
-)-(1→ Chevolot et al., 2001 [57] 
A. nodosum  (1→3)--L-Fucp and a few (1→4)--L-Fucp with (1→3)--L-(2 
and/or 4 Fucp) 
Marais et al., 2001 [61] 
Chorda filum  -[→3)--L-Fucp-(1-]3→3)--L-Fucp(2Fucp)-(1→ Chizhov et al., 1999 [62] 
Fucus distichus L.  →3)--L-Fucp-(2,4-diSO3
−)-(1→4)--L-Fucp-(2SO3
−)-(1→ Bilan et al., 2004 [63] 
F. evanescens  →3)--L-Fucp(2SO3
-)-(1→4)--L-Fucp(2SO3
-)-(1→ Bilan et al., 2002 [64] 
F. serratus L  →3)--L-Fucp(2R1,4R2)-(1→4)--L-Fucp(2SO3
−)-(1→ 
a.  (~50%): R1 = SO3
−, R2 = H 
b.  (~50%): R1 = H, R2 = -L-Fucp-(1→4)--L-Fucp(2SO3
−)-(1→3)-
-L-Fucp(2SO3
−)-(1→ 
Bilan et al., 2006 [65] 
Laminaria 
saccharina 
→3)--L-Fucp(4SO3
-)-(1→ and additionally →3)--L-Fucp(4SO3
- or 
2Fucp)-(1→ 
Usov et al., 1998 [66] 
Stoechospermum 
marginatum 
→3)--L-Fucp(2/4SO3
−)-(1→ and 
→4)--L-Fucp(2SO3
−)-(1→ 
Adhikari et al., 2006 [67] 
Many fucans from brown algae contain small amounts of other monosaccharides, including 
glucose [68], galactose [69], mannose [70–72], xylose [69,73], uronic acids [68,74] and also acetyl 
groups [75].  
3. Approaches in Structural Analysis of Algal Sulfated Polysaccharides 
3.1. Desulfation and Methylation for Structure Analysis 
Structure analysis of sulfated polysaccharides requires determination of the attached sulfate esters 
along their backbones and the glycosidic linkage types. Methylation is used to determine linkages 
between monsaccharides. By comparing the methylation of native polysaccharides to that of their 
desulfated counterparts, the positions of the sulfate groups can be determined. Thus, hydrolysis of the 
permethylated, desulfated polysaccharides, yields partially methylated monosaccharides, which 
following acetylation are separated and identified on gas chromatography/mass spectra [76].  
Accurate structural determination requires desulfation of the polysaccharide without cleavage of the 
polysaccharides chain linkages. Often a solvolytic desulfation procedure is used wherein the 
polysaccharide as a pyridinium salt is heated in dimethyl sulfoxide [47,77,78]. Desulfation of fucoidan 
by methyl sulfoxide-pyridine is rapid and complete, resulting in higher yields with little degradation. 
However, a method using chlorotrimethylsilane (CTMS) for treatment of pyridinium salts is more 
appropriate for desulfation of sulfated galactans of both the agaran and carrageenan families [79]. 
Other approaches for desulfation that have been used involve methanolic hydrogen chloride [80], 
silylating reagents [81], and pyromellitic acid [82]. Chemical desulfation is relatively non-specific and 
usually results in a significant loss of sample material. The use of sulfatases represents a more specific 
approach to desulfation and would be advantageous in structural studies, yet such enzymatic Mar. Drugs 2011, 9 
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approaches do not appear to be a frequent method of choice [7,83]. The reason for this is unclear but 
could be due to the lack of commercially available enzymes of the required specificity. 
The typical methylation procedure is straightforward, involving treating the desulfated 
polysaccharide sample with methyl iodide in the presence of solid base, usually sodium hydroxide, in 
methyl sulfoxide and the procedure can be repeated to obtain a complete methylation [51,62,77,84,85]. 
3.2. Structural Analysis by Using NMR and MS 
A powerful tool for the structural elucidation of sulfated polysaccharides is NMR spectroscopy, 
which can provide structural details such as the monosaccharide components, linkages, anomeric 
configurations, and positions of branching or sulfations. This can be done by combining various 1D 
and 2D-NMR techniques. The use of NMR in the structural analysis of red algal galactans and green 
algal ulvans has been considerable [3,86]. In part, this has been due to the relative high proportion of 
repeating sequences (identical sulfation pattern) in these polysaccharides that make them amenable to 
analysis by 
13C-NMR. For example, Gonçalves and colleagues described the structural elucidation by 
NMR of positional isomers of sulfated oligosaccharides obtained from agarans and carrageenans [87]. 
This entailed partial reductive hydrolysis to produce oligosaccharides from repetitive galactans 
followed by separation by anion exchange and gel-filtration chromatography prior to 1D and   
2D NMR analysis. 
Effort has also been made to elucidate the structures of fucans by NMR. Usov et al., by 1D-NMR, 
found the sulfated fucans from Saccharina latissima (formerly  Laminaria saccharina) to be 1→3 
linked -L-fucopyranose with a sulfate group at C4 and branched at C2 [66]. More recently, they 
confirmed the complex structure of this fucoidan with a more detailed structural investigation by   
2D-NMR [88]. These studies also revealed the presence of three additional sulfated polysaccharide 
types, a fucogalactan, a fucoglucuronomannan and a fucoglucuronan, that appear to occur in minor 
amounts in their preparation.  
Mass spectrometry (MS) is valuable in the structural analysis of polysaccharides, as it generates 
accurate molecular mass data for oligosaccharides and it can also provide sequence information. 
Compared with other analytical techniques, mass spectrometric methods have several advantages, 
including low sample consumption (e.g., picomole quantities) and short analysis time. While analysis 
of sulfated polysaccharides by MS can be problematic due to the labile nature of the sulfate groups, 
approaches based on electrospray ionization and matrix-assisted laser desorption/ionization (MALDI) 
are increasingly being developed to characterize sulfated oligosaccharides [89–92]. Negative-ion   
ESI-CID-MS/MS was used to characterize oligosaccharide fragments derived from mild hydrolysis of 
κ-carrageenan that revealed highly ordered disaccharide repeats leading to a complete series of 
exclusively odd-numbered oligosaccharides [92]. Similarly, fucan oligosaccharides from A. nodosum, 
including a highly sulfated pentasaccharide, were analyzed successfully by negative ion ESI-MS [89]. 
3.3. Oversulfation of Algal Polysaccharides 
Structure modification of sulfated polysaccharides, such as desulfation, oversulfation, acetylation 
and benzoylation, would allow the development of new and possibly more effective derivatives of 
naturally occurring polysaccharides [93–95]. For example, benzoylated derivatives of native ulvan Mar. Drugs 2011, 9 
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from  Ulva pertusa exhibited enhanced antioxidant properties [94]. Certainly, the most frequent 
structural modification to sulfate polysaccharides is oversulfation due to the typically strong positive 
correlation between their sulfate content and biological activity (discussed further in Section 4). A 
number of methods have been developed for polysaccharide oversulfation, such as treatment with 
sulfuric acid, sulfur trioxide-pyridine, chlorosulfonic acid-pyridine, dimethylformamide and sulfur 
trioxide-dimethylamine [96–102]. 
3.4. Molecular Size Modification of Algal Sulfated Polysaccharides 
Lower molecular weight algal sulfated polysaccharides can be prepared by chemical, physical or 
enzymatic means to obtain oligosaccharides with more diverse bioactivities. For example, linear or 
branched sulfated galactans and fucans can be cleaved by mild acid hydrolysis [99,102] or by a radical 
process involving a hydrogen peroxide-cupric redox system [98,101]. The chemical methods are easy 
to perform but lack specificity. Minor changes in temperature or acidity can lead to variations in 
oligosaccharide sizes and sulfation patterns, while strong acid may alter the sulfation pattern or destroy 
the polysaccharide chain [97]. Enzymatic degradation of sulfated polysaccharides can be achieved by 
selecting enzymes such as hydrolases, fucoidanases (EC 3.2.1.44), -L-fucosidases (EC 3.2.1.51) and 
galactosidases [96,103] to target glycosidic bonds while preserving the sulfate groups [100]. 
Fucoidanases and galactosidases have been identified in marine invertebrates and 
microorganisms  [83,104–108]. Some bioactivities of lower molecular weight oligosaccharides 
prepared from algal sulfated polysaccharides are highlighted in Table 2. 
Table 2. Biological activities of selected low molecular weight oligosaccharides derived 
from algal sulfated polysaccharides. 
Modification methods  Source  Applications  Reference 
Chemical  Ascophyllum nodosum  Antithrombotic activity  Colliec-Jouault et al., 2003 [109] 
Botryocladia occidentalis  Anti-venom activity  Toyama et al., 2010 [110] 
Furcellaria lumbricalis  Immunostimulation activity  Yang et al., 2011 [16] 
Solieria chordalis  Immunostimulation activity  Bondu et al., 2010 [111] 
Enzymatic  Chondrus ocellatus  Anti-tumor activity  Mou et al., 2003 [112] 
Nemacystus decipieus  Anticoagulant activity  Kitamura et al., 1992 [113] 
Pelvetia canaliculata  Antiviral activity  Klarzynski et al., 2003 [114] 
Undaria pinnatifida  Anticoagulant activity  Kim et al., 2010 [115] 
4. Bioactivity and Structure-Activity Relationship 
Due to the difficulties in identifying the chemical structure of algal sulfated polysaccharides, the 
relation between their structures and biological activities is not completely understood. One of the 
research approaches in establishing structure-function relationships has been to make inferences based 
on information obtained from studies of invertebrate sulfated polysaccharides that have a regular 
structure and so are more easily studied. For example, Pereira and colleagues compared branched 
fucans from brown seaweeds with the more simple linear versions obtained from sea cucumber and sea 
urchins [116]. The anticoagulant activity of seaweed fucans was shown to depend on their molecular Mar. Drugs 2011, 9 
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weight, the extent of sulfation, and the distribution of sulfate groups in the repeating units. 
Interestingly, the algal fucans were found to inhibit coagulation through a direct inhibition of thrombin 
whereas the invertebrate fucans inhibited the enzyme indirectly with a requirement for antithrombin 
and heparin cofactor II. 
In this section, we will highlight the key biological activities that have been reported for algal 
sulfated polysaccharides, the current knowledge regarding their mode of action and the structural 
requirements necessary to elicit these effects. 
4.1. Anticoagulant and Antithrombotic Activities 
Probably the most widely recognized and studied bioactivity of marine sulfated polysaccharides is 
the heparin-like anticoagulant activity exhibited by fucoidans and other fucans of brown seaweeds. 
This was first reported for fucoidan isolated from F. vesiculosus by Springer and colleagues who found 
inhibition of fibrin clot formation and antithrombin activity [117,118]. Since then, studies on fucans 
from various seaweeds have revealed anticoagulant and antithrombotic activities and are discussed in 
several recent reviews [1,4,6]. 
The basis for these activities is not completely understood, but a number of investigations suggest 
more than one mechanism of action including direct and indirect inhibition of thrombin through the 
activation of thrombin inhibitors (e.g antithrombin and heparin cofactor II) [116,119–121]. Recently, 
Cumashi and colleagues reported that fucans from 10 brown seaweeds each prolonged the clotting 
time of human plasma; however, only five of these fucans had significant activity against thrombin-
induced platelet aggregation [122]. While the results of the latter assay are suggestive of a direct action 
of certain fucans on thrombin, the authors pointed out that an interfering action of thrombin binding to 
its receptors on platelets could not be ruled out.  
The general structural features of fucans that are important in their anticoagulation activity include 
sugar composition, molecular weight, sulfation level and the position of sulfate groups on the sugar 
backbone [70,123–125]. For example, Nishino and colleagues found that a higher content of fucose 
and sulfate groups coincided with higher anticoagulant activities in sulfated polysaccharide fractions 
from  E. kurome [70]. They also showed that anticoagulation activity of fucans was positively 
correlated with sulfate content and that only fucans with a sulfate-total sugar residue ratio greater than 
one possessed significant activity [93,123]. Higher molecular weight fucans (e.g., 27 and 58 kDa) 
showed greater anticoagulant activity than lower molecular weight ones (~10 kDa) [126]. The 
relationship between molecular weight of sulfated polysaccharides and their anticoagulant activity was 
also considered by Pomin and colleagues who reported that linear, sulfated fucan required significantly 
longer chains than mammalian glycosaminoglycans to achieve anticoagulant activity [125]. Selective 
cleavage to reduce molecular size of the fucan by only a modest amount dramatically reduced its effect 
on thrombin inactivation mediated by heparin cofactor II. Lower molecular weight fucans appear to 
bind to heparin cofactor II but, unlike the native (full length) fucan, were unable to effectively 
facilitate the heparin cofactor II interaction with thrombin [125]. Chevolot et al. reported on the 
importance of sulfate group location on the sugar residues for anticoagulant activity [57,62]. Studying 
the fucoidan from A. nodosum, they found that anticoagulant activity required 2-O-sulfated and 2,3-O 
disulfated fucose residues, whereas sulfation at the O-4 position did not appear necessary.  Mar. Drugs 2011, 9 
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Marine sulfated polysaccharides other than fucans have also been shown to possess anticoagulant 
activities. Reports include sulfated galactan and ulvan-like sulfated polysaccharides obtained from 
green algae, in particular from species of Codium and Ulva [44,45,49,127,128]. For example, Mao et 
al. described a sulfated polysaccharide from U. conglobata with high rhamnose content and 35% 
sulfate ester that prolonged clotting time through what appeared to be direct inhibition of thrombin and 
modulation of heparin cofactor II [49]. Hayakawa et al. tested sulfated polysaccharides from 23 green 
algae species for anticoagulant activity and discovered a high rhamnose-containing sulfated 
polysaccharide from Monostroma nitidum, the purified version of which was more potent than 
standard heparin [127].  
Red seaweeds have also yielded a number of sulfated polysaccharides with potent anticoagulant 
activities [129–131]. Studies on a sulfated galactan from the red seaweed Botryocladia occidentalis are 
particularly illustrative. Farias et al. reported that a 2,3-di-O-sulfated D-galactan from B. occidentalis 
exhibited anticoagulant activity, comparable to heparin, which appeared to be due to inhibition of 
thrombin and factor X. Its activity was more potent than similar sulfated galactans, from invertebrate 
sources, that had only one sulfate per galactose residue [129]. A similar polysaccharide chain from 
G. crinale, but with lower amounts of 2, 3-di-O-sulfated D-galactose, was less potent in a clotting time 
assay when compared with that from B. occidentalis [131]. The two sulfated polysaccharides did not 
differ in thrombin inhibition mediated by antithrombin; however, in assays where heparin cofactor II 
was used in place of antithrombin, the sulfated galactan from G. crinale was less inhibitory than that 
from B. occidentalis. Yet the sulfated galactan from G. crinale was a more potent anticoagulant than 
that from B. occidentalis when Factor X was the target protease. These observations suggested that the 
proportion and/or the distribution of 2,3-di-sulfated galactose along the polysaccharide chain modulate 
the interaction of the polysaccharides with specific proteases in the coagulation system. Recently, 
Glauser et al. showed that the 2,3-disulfated galactan from B. occidentalis inhibits intrinsic tenase and 
prothrombinase complexes that are critical for factor Xa and thrombin generation, respectively [130]. 
The sulfated galactan interacts with the heparin-binding site on the heavy chain of factor Xa. 
Interestingly, the anticoagulant activities associated with the sulfated galactan and that of heparin are 
modulated differently by heparin cofactor II; heparin anticoagulant activity was enhanced in plasma 
devoid of heparin cofactor II, whereas the activity of the sulfated galactan was independent of   
this cofactor.  
Heparin is used extensively for the prevention of venous thrombosis and the treatment of other 
thromboembolic disorders due to its inhibition of thrombin and other enzymes in the coagulation 
system. To overcome the obvious potential side-effect of bleeding, researchers have investigated 
means of reducing the anticoagulant activities of heparin while enhancing its anti-thrombotic activities 
including chemical modification and fractionation of native heparin to lower molecular forms   
[132–134]. Nevertheless, the development of antithrombotic algal polysaccharides would be 
advantageous since their use would avoid the potential for contamination with prions or viruses in 
commercial heparins, which are obtained from pig and bovine intestine. Moreover, with more specific 
activities and/or targets, the algal sulfated polysaccharides could find applications complementary to 
heparin [132]. To this end, one of the approaches has been to develop low molecular weight (LMW) 
fucoidans [121,135]. For example, a LMW fraction of approximately 8,000 derived from the fucoidan 
of A. nodosum reduced mean thrombus weight by 80% vs. control saline injection in a rabbit model of Mar. Drugs 2011, 9 
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venous thrombosis [135]. This LMW fucoidan and related derivatives [136] are promising since they 
show lower effects in coagulation tests when compared to the commercial LMW heparin, dalterparin 
(Fragmen®, Pfizer Inc.). More recently, Rocha and colleagues reported that a sulfated galactofucan 
from the brown seaweed Spatoglossum schoederi has potent antithrombotic activity in a rat model of 
venous thrombosis [69]. Unlike heparin, which produces a rapid but transient antithrombotic effect, the 
in vivo action of this sulfated galactofucan progressed slowly, showing maximal effectiveness about 
eight hours post injection. When tested in vitro using endothelial cells, it was discovered that the 
galactofucan stimulates the production of heparan sulfate leading to the hypothesis that its delayed 
action in vivo is tied to the need for an accumulation of the heparan sulfate on blood vessel surfaces. 
Despite its high sulfation level, the galactofucan lacks significant anticoagulation activity, making it an 
ideal candidate as an antithrombotic agent [69].  
4.2. Antiviral Activity  
The ability of sulfated polysaccharides from seaweeds to inhibit the replication of enveloped viruses 
including herpes simplex virus (HSV), human immunodeficiency virus (HIV), human 
cytomegalovirus, dengue virus and respiratory syncytial virus is well established [137–140]. The 
original observations on antiviral activities of seaweed constituents go back more than 50 years to the 
observation that seaweed extracts protected chicken embryos against influenza B and mumps [141].  
It was discovered a little later, somewhat serendipitously, that heparin inhibited HSV in leukocyte 
cultures [142], an effect hypothesized to be due to electrostatic interference with viral attachment to 
the cell surfaces. This spurred research into the antiviral effects of various polyanionic substances 
including sulfated polysaccharides from a number of seaweed species. Interest around the antiviral 
effects of algal polysaccharides has grown substantially in recent years with the mounting evidence 
that their effects on viral replication occurs by a number of mechanisms that involve specific structural 
qualities of the polysaccharides and not simply through non-specific interactions [137,143]. We will 
discuss some of the more recent findings regarding the structural requirements of algal polysaccharides 
for antiviral activity and the underlying modes of action.  
A fucan from Cladosiphon okamuranus composed of glucuronic acid and sulfated fucose units 
potently inhibited infection of BHK-21 cells with dengue virus type 2 (DENV-2), but showed little 
effect on the other three serotypes of the virus [144]. Sulfation of the fucan was necessary for this 
activity; surprisingly, carboxyl-reduction of the glucuronic acids to glucose units also abolished the 
fucans’ antiviral properties. Analysis of the structure of the envelope glycoproteins from the four 
serotypes of dengue virus suggested that arginine-323 in DENV-2, which is proximal to the putative 
heparin binding site, was critical for the interaction with the fucan.  
Similarly, Talarico and colleagues reported that two sulfated polysaccharides from red seaweeds, a 
carrageenan from Gymnogongrus griffithsiae and a galactan from Cryptonemia crenulata, inhibited 
DENV-2 multiplication in Vero cells [145–147]. Their effects were less potent against DENV-3 and 
DENV-4 and were completely inactive against DENV-1 infection [147]. These polysaccharides were 
shown to interfere with both DENV-2 adsorption and internalization into the cells and were only 
effective if added together with the virus or shortly after infection. For example, no inhibition of virus Mar. Drugs 2011, 9 
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multiplication occurred when the normal viral entry process was bypassed by DENV-2 RNA 
transfection into the cells [145,146]. 
Recently, light has also been shed on the antiviral activity of marine sulfated polysaccharides 
against HSV types 1 and 2 (HSV-1, HSV-2) [67,143,148,149]. Sulfated xylomannans from the red 
seaweed Sebdenia polydactyla inhibited the propagation of HSV-1 in Vero cells [148]. The activity 
was abolished by desulfation of the xylomannan and, conversely, oversulfated derivatives exhibited 
enhanced potency. Mohsen reported that sulfated polysaccharide fractions isolated from Sargassum 
latifolium inhibited HSV-1 in the plaque assay with the most effective fraction having greater sulfate 
ester content and molecular weight compared to the other fractions studied [150]. It has been generally 
observed that antiviral activity of sulfated polysaccharides increases with their molecular weight [137]. 
Representative polysaccharides from brown and red seaweeds differing in structure (galactans, fucans 
and galactofucans), sulfation level and molecular weight were shown to inhibit HSV-1 and HSV-2 
infection [149] reinforcing the view that, as with other activities, antiviral activity of sulfated 
polysaccharides is due to a complex interplay of structural features including sulfation level, 
distribution of sulfate groups along the polysaccharide backbone, molecular weight, sugar residue 
composition, and stereochemistry [139,143]. A subset of these sulfated polysaccharides also showed 
an ability to inactivate HSV-2 directly through incubation with the virus. This virucidal activity has 
significance since it is associated with augmentation of antiviral activity in vivo [151]. 
4.3. Immuno-Inflammatory Activity 
Sulfated polysaccharides, including those from algae, have been shown to possess 
immunomodulatory activities that may be of potential application in stimulating the immune response 
or in controlling immune cell activity to mitigate associated negative effects such as inflammation 
[152]. Sulfated polysaccharides may affect multiple targets in the immune and inflammatory systems 
that can have impact on disease progression and outcome including tumor progression and   
metastasis [153].  
One of the interests in algal sulfated polysaccharides as anti-inflammatory agents is the growing 
body of evidence illustrating their ability to interfere with the migration of leukocytes to sites of 
inflammation. For example, in a rabbit model of bacterial meningitis, leukocyte rolling was markedly 
reduced by intravenous infusion of fucoidan [154]. Similarly, intravenous addition of fucoidan 
reduced, in a dose-dependent manner, leukocyte recruitment to peritoneum in a rat model of peritoneal 
inflammation [155]. These effects were ascribed to the binding of fucoidan to L- and P selectins, cell 
adhesion molecules essential in the recruitment process. Both of these studies used the fucoidan from 
Sigma-Aldrich Chemical Co (St. Louis, MO, U.S.) that is sourced from F. vesiculosus. Fucans from 
other seaweeds including Laminaria spp., Fucus spp., A. nodosum, and C. okamuranus also inhibit 
leukocyte recruitment to the abdominal cavity during acute peritonitis in rats [122]. In addition to 
impairing the action of selectins, algal sulfated polysaccharides inhibit tissue degradative enzymes 
such as heparanase and elastases that are involved in the breakdown of basement membrane integrity 
during inflammation [156,157].  
One of the major and potentially promising activities is the potent inhibitory effect of sulfated 
fucans on human complement activation. The original observations showed that fucoidan fractions Mar. Drugs 2011, 9 
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from A. nodosum potently inhibit both the classical and alternative pathways in human serum [158]. 
Tissot and colleagues have extensively studied this activity [159–162]. It was determined that low 
molecular weight fucoidan fractions bind to the C1q subunit of the C1 complex that triggers 
complement through recognition and binding of immune complexes [162]. The binding of fucoidan 
appears to interfere with the ability of C1q to fully trigger C1 activation [160]. Fucoidan also binds C4, 
thereby preventing its breakdown and generation of its cleavage product C4b, the latter being required 
for the formation of C3 convertase and the propagation of complement [162]. Furthermore, it was 
found that fucoidan binds C1q globular heads and may interfere with C1q recognition of IgG [161]. 
Recently, using NMR, it was found that branched fucoidan oligosaccharides are better at inhibiting 
complement compared to linear structures [159].  
The interaction of algal sulfated polysaccharides with the complement system suggests that they 
may have utility in influencing innate immunity to reduce the pro-inflammatory state or other 
detrimental conditions such as allergic reactions arising during the innate immune response. In 
addition, there is a growing body of evidence that algal polysaccharides can regulate the innate 
immune response directly by binding to pattern recognition receptors (PRRs) such as the mannose 
receptor and toll-like receptors on phagocytic cells including macrophages [152]. For example,   
λ-carrageenan stimulated mouse T cell cultures in a toll-like receptor-4 (TLR4) dependent manner 
[163] generating a T helper 1 (Th1) patterned cytokine response. However, splenocytes prepared from 
TLR4-deficient mice still retained some ability to produce interferon-γ in response to λ-carrageenan 
suggesting that PRRs other than TLR4 were also elicited. In mice immunized with ovalbumin to 
produce an allergic reaction, oral dosing with λ-carrageenan lead to a reduction in ovalbumin-specific 
IgE and serum histamine release, suggesting that λ-carrageenan might be used to ameliorate allergic 
reactions. Similar results were reported for mekabu fucoidan from U. pinnatifida [164].  
Direct stimulatory effects of algal polysaccharides on immune cells results in production of nitric 
oxide through induction of inducible nitric oxide synthase (iNOS) and a pro-inflammatory 
cytokine/chemokine profile [165]. Depending on the situation, the interaction of sulfated 
polysaccharides with other effectors may result in reduced inflammation. For example, fucoidan from 
F. vesiculosus induced iNOS in RAW264.7 macrophage cells leading to enhanced production of nitric 
oxide [166,167]. Yet, in the presence of lipopolysaccharide (LPS), the fucoidan impaired   
LPS-induced expression of iNOS and nitric oxide production [167]. Similarly, fucoidan suppresses 
interferon gamma-induced iNOS expression in macrophage and glial cell types [168].  
These and other reports of algal sulfated polysaccharides directly stimulating the innate immune 
system [165,168–170] suggests that they may find therapeutic use in opposing T helper 2 (Th2)-based 
pathologies such as autoimmune disorders and allergy. Additionally, there is evidence that algal 
sulfated polysaccharides including fucoidans and carrageenans increase the cytotoxicity of natural 
killer cells, lymphocytes and macrophages against tumors [169,171].  
The structural requirements for this immunostimulatory activity of algal sulfated polysaccharides 
have not been greatly studied. One report, by Leiro and colleagues, has shown greatly diminished 
immunostimulatory activity of ulvan-like polysaccharides from U. rigida when they were   
desulfated [165].  
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4.4. Antioxidant Activities 
Algal sulfated polysaccharides, until recently, were largely ignored as sources of antioxidant 
activity. Studies over the last several years reveal that sulfated polysaccharides from a number of 
seaweeds have appreciable antioxidant capability [95,172–177]. For example, fucans from 
F. vesiculosus exhibited considerable ferric reducing/antioxidant power [172] and superoxide radical 
scavenging ability [173]. Fucan fractions from L. japonica also showed significant antioxidant 
capabilities in superoxide radical and hydroxyl radical scavenging assays [174,176,177]. Superoxide 
radical scavenging activity correlated positively with the sulfate content of the polysaccharide fractions 
[173,176]. Antioxidant properties of carrageenans [173] and ulvans [94] also appeared related to 
sulfate content. In the latter study, high sulfate content derivatives of ulvan showed improved 
antioxidant activities [94]. Interestingly, metal chelating, free radical and hydroxyl radical scavenging 
activities of fucan fractions appear to relate to their ratio of sulfate content/fucose [176].  
4.5. Antilipidemic Effects 
Algal sulfated polysaccharides exert lipid-lowering and other beneficial properties in 
hyperlipidemic animal models [178–180]. An extract from F. vesiculosus, in a dose-dependent 
manner, effectively reduced the elevation in serum triglyceride and total cholesterol levels in   
triton-induced-hyperlipemic rats. In rats fed a high cholesterol diet for 21 days, supplementation of the 
diet with ulvan from U. pertusa led to reductions in serum total cholesterol and LDL-cholesterol with 
no significant alteration in serum triglycerides [180]. The effects of ulvan were modified when it was 
degraded into lower molecular weight fractions. Ulvan derivatives of lower molecular weight and 
intrinsic viscosity did not reduce serum cholesterol but did normalize the hypertriglyceridemia of these 
animals and raised HDL-cholesterol. The underlying mechanisms of these actions are unclear but it 
does not appear to involve bile acid sequestration since ulvan and its lower molecular weight 
derivatives increased bile excretion to a similar extent.  
Recently, it was reported that fucoidan from L. japonica reduced serum total and LDL-cholesterol 
and triglycerides and raised HDL-cholesterol in a hyperlipidemic rat model [179]. The treatment also 
increased the activities of lipoprotein lipase (LPL), hepatic lipase (HL) and lecithin cholesterol 
acyltranferase (LCAT) in serum. These changes in enzyme activities could be the direct result of 
fucoidan treatment or an indirect effect associated with improvement in lipid profile. Certainly 
fucoidan and other algal sulfated polysaccharides may influence LPL and HL through interaction with 
well-characterized heparin-binding sites on these enzymes. Consistent with this is the observation that 
fucoidan from F. vesiculosus releases LPL from cell surface binding sites and stabilizes LPL activity 
in culture medium [181].  
Algal sulfated polysaccharides are showing promising effects in addressing the hyperlipidemia 
associated with certain drug toxicities. Fucans from S. polycystum were shown to have significant 
preventive effects on the elevation of cholesterol and triglycerides in serum and liver tissue resulting 
from acetaminophen-induced toxic hepatitis [182]. Treatment also partially reversed the reduction in 
hepatic LCAT and HL and improved overall histological appearance of the liver. Similarly, a sulfated 
polysaccharide from S. wightii reduced hyperlipidemia and normalized LPL and LCAT in plasma in Mar. Drugs 2011, 9 
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cyclosporine A-induced nephrotoxicity [183]. The excretion of urea, uric acid, and creatinine were 
normalized by the sulfated polysaccharide treatment. In addition, the susceptibility of LDL to 
oxidation was reduced, suggesting that the antioxidant activity of the sulfated polysaccharide was also 
playing a role and may contribute to its renoprotective activity.  
5. Future Perspectives 
Algal sulfated polysaccharides are a source of numerous biological activities that may find 
therapeutic benefit. They are structurally diverse and heterogeneous, which makes studies of their 
structures challenging, and may also have hindered their development as therapeutic agents to date. 
The production of a standardized commercial product based on algal sulfated polysaccharide 
constituents will be a challenge since their structural and pharmacological features may vary 
depending on species and on location and time of harvest. For example, Bourgougnon and colleagues 
reported that there was a significant annual variation in the composition and the in vitro anti-HIV-1 
activity of a water-soluble sulfated glucuronogalactan from Schizymenia dubyi [184]. Another issue to 
the therapeutic use of algal polysaccharides is their potentially low bioavailability given their often 
high molecular weights. It is likely, based on observations with heparin [185], that algal sulfated 
polysaccharides will display some, albeit low, degree of oral bioavailability. A recent pilot study in 
humans reported that fucoidan was ineffective as an oral anticoagulant agent [186], which underscores 
the issue. It also emphasizes the importance of understanding the structural requirements for biological 
activity and whether low molecular weight derivatives, which are potentially more bioavailable, 
remain active. For some applications, low bioavailability may not be a concern. First, some of the 
hypolipidemic effects of seaweed sulfated polysaccharides arise through effects on bile acid 
sequestration in the intestinal lumen. Second, for some immunomodulatory activities, the site of 
activation of the immune system may also be within the intestinal lumen (e.g., at Peyer’s patches) as 
has been hypothesized for immunomodulatory effects of polysaccharide constituents from Chlorella 
pyrenoidosa [187]. Finally, algal sulfated polysaccharides are already used topically in cosmetics and 
there is significant interest in further development for cosmetics and cosmeceuticals products [188].  
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